GX-19 induced potent CD4+ and CD8+ T cells in both animal models and it may confer long-lasting immunity against coronaviruses as indicated in SARS survivors, where CD8+ T cell immunity persisted up to 11 years [44,51]. The gene discussed is CD4; the disease is severe acute respiratory syndrome.